Public Health | November 16, 2021
Biocon Biologics partners with RSSDI to expand insulin access
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The company performed particularly well in operational eco-efficiency, environmental and social reporting
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
The centre has an initial capacity of 500 FTEs
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
Subscribe To Our Newsletter & Stay Updated
